Cytek Biosciences CTKB
NASDAQ CTKB
$5.96 +0.20 (+3.47%)
At close: Sep 30, 2026 · 4:00 PM EDT

Cytek Biosciences (CTKB) Current Deferred Revenue (2020 - 2026)

Updated

Cytek Biosciences (CTKB) reported Current Deferred Revenue of $29.21 million for Q2 2026, up 3.8% from $28.13 million a year earlier but down 2.8% from the prior quarter.

Analysis

Cytek Biosciences (CTKB) Current Deferred Revenue (2020 - 2026) Analysis & Trends

At the end of FY2025, Cytek Biosciences posted Current Deferred Revenue of $28.5 million, up 11.8% from FY2024.

  • Current Deferred Revenue has increased for five consecutive years, with a five-year compound annual growth rate of 50.7% (FY2020 to FY2025).
  • By year, Current Deferred Revenue came in at $25.49 million in FY2024 (+12.3%), $22.7 million in FY2023 (+74.8%), $12.99 million in FY2022 (+83.4%) and $7.08 million in FY2021 (+93.2%).
  • Five-year quarterly Current Deferred Revenue spans a low of $5.89 million in Q3 2021 and a high of $30.03 million in Q1 2026.
  • Year over year, Current Deferred Revenue has now increased in each of the last 17 quarters, with growth averaging 12.2% over the last eight quarters.
  • The year-over-year growth in Current Deferred Revenue has ranged between 3.8% (Q2 2026) and 114.0% (Q2 2022) over the last five years.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $30.03 million (Q1 2026), $28.5 million (Q4 2025) and $28.74 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Cytek Biosciences 774.70 Mn 450.97 Mn 28.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.21 Mn
Mar 31, 2026 30.03 Mn
Dec 31, 2025 28.50 Mn
Sep 30, 2025 28.74 Mn
Jun 30, 2025 28.13 Mn
Mar 31, 2025 27.71 Mn
Dec 31, 2024 25.49 Mn
Sep 30, 2024 25.37 Mn
Jun 30, 2024 23.97 Mn
Mar 31, 2024 23.01 Mn
Dec 31, 2023 22.70 Mn
Sep 30, 2023 23.05 Mn
Jun 30, 2023 20.61 Mn
Mar 31, 2023 18.10 Mn
Dec 31, 2022 12.99 Mn
Sep 30, 2022 12.09 Mn
Jun 30, 2022 9.99 Mn
Mar 31, 2022 12.25 Mn
Dec 31, 2021 7.08 Mn
Sep 30, 2021 5.89 Mn
API Access

Cytek Biosciences Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CTKB&period=max&api_key=YOUR_API_KEY